利伐沙班价格

Rivaroxaban is jointly developed by Bayer and Johnson & Johnson, with the trade name Xarelto. Rivaroxaban is a highly selective, oral drug that directly inhibits factor xa. By inhibiting factor xa, the endogenous and exogenous pathways of the coagulation cascade can be interrupted, and the generation of thrombin and thrombosis can be inhibited.

The recommended dose of Rivaroxaban is 10 mg of Xarelto taken orally once daily. If the wound has stopped bleeding, the medication should be administered between 6-10 hours after surgery. The length of treatment is determined by each patient's risk of VTE, i.e. by the type of orthopedic surgery the patient has undergone.

For the prevention of venous thrombosis in adult patients undergoing elective hip or knee replacement surgery: The recommended dose is rivaroxaban 10 mg orally once daily. If the wound has stopped bleeding, the first dose of medication should be between 6 and 10 hours after surgery. For patients undergoing major hip surgery, the recommended course of treatment is 35 days. For patients undergoing major knee surgery, the recommended course of treatment is 12 days. If a missed dose occurs, the patient should take rivaroxaban immediately and continue taking the dose once daily the next day.

Rivaroxaban is rapidly absorbed after oral administration. Peak concentration can be reached 2 to 4 hours after administration of 2.5 to 80 mg. It can be administered in multiple doses without accumulation within a reasonable range. It is eliminated in its original form by the kidneys and undergoes metabolic degradation. Multiple studies have shown that oral Rivaroxaban has few interactions with food and drugs. It is currently a relatively safe and effective treatment method that does not require laboratory monitoring.

It is understood that Rivaroxaban is currently on the market in many countries or regions. What is the price of Rivaroxaban?

Rivaroxaban specifications are 15mg*28 tablets; 20mg*28 tablets are priced around $600. For detailed prices, patients can consult their medical companion.